Navigation Links
ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
Date:2/20/2008

HALIFAX, Feb. 20 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, announced today the appointment of former senator, Michael Kirby, as the new Board of Directors Chair. Michael Kirby succeeds the late Dr. Warrick Kimmins, who provided exemplary leadership during his tenure and was instrumental in spinning out IVT's novel technology from Dalhousie University.

"I am passionate about advancing health care and am delighted to be part of such a fast-growing biotech company," said former senator Michael Kirby. "IVT has an impressive track record and its patented technology holds tremendous potential to improve vaccines worldwide. "

"Michael Kirby is an internationally respected leader in health care," said Dr. Randal Chase, IVT President and CEO. "His strategic advice will be invaluable, as we enter the next phase of development with the expectation of beginning a new Phase 1 clinical trial in 2009."

The Honourable Michael Kirby has had a distinguished career spanning academia, business, provincial, and federal public service. Most recently, he was appointed, by Prime Minister Stephen Harper, to be the first Chair of the Mental Health Commission of Canada. He also serves on several boards including The Bank of Nova Scotia, Extendicare, Ontario Energy Savings Income Trust, MDC Partners, and Indigo Books and Music.

Senator Kirby was past chair of the Standing Senate Committee on Social Affairs, Science and Technology. He has been a member of the Trilateral Commission, the Council of the International Institute for Applied Systems Analysis, Luxemburg, Austria, and the Club of Rome. He was also a full-time professor in the School of Business Administration and the School of Public Administration at Dalhousie University.

About IVT

ImmunoVaccine Technologies Inc. is a private, clinical-stage, vaccine development company. Through its own biotech research and collaborations with partners, IVT cre
'/>"/>

SOURCE ImmunoVaccine Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. ImmunoVaccine Technologies Inc. Nears Phase I Clinical Trials with Completion of Scientific Advisory Board
2. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
3. NASA MidSTAR-1 successful technologies may be revolutionary
4. Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
5. Neurobiological Technologies Sets Date for Research and Development Day
6. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q2/08 Review Issued By Scimitar Equity Research, Inc.
7. Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations
8. Emisphere Technologies to Web Cast BIO CEO & Investor Conference Presentation February 12
9. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
10. Newly Appointed Dilon Technologies President & CEO Robert G. Moussa Sees BSGI as ... Major Weapon in the Battle Against Cancer
11. Genelabs Technologies to Present at the BIO CEO & Investor Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...T, Calif., Nov. 5 WaferG...leading developer of state-of-the-art genetic anal...rs, Ph.D. has joined the company,s Scientific Advi...ing and commercializing novel molecular diagnostic... on the development of computational biology syste...
(Date:11/5/2009)... LASIK Surgery and vision correction ...tory were actively involved at the recently conclu...nnual Meeting in San Francisco, California. Dr. St.... Jonathan Davidorf, MD, Dr. Peter Rapoza, MD, Dr....R. Wayne Bowman, MD, Dr. Edward Manche, MD, and Dr...
(Date:11/4/2009)...ILLE, Ala., Nov. 4 DIATHERIX Labor... today presented at the Michigan Security Network ...Dearborn, Mich. Dennis Grimaud, Chairman and Chief...act of the company,s advanced molecular diagnostic...nfectious disease diagnosis and military efforts. ...
(Date:11/4/2009)...RLOS, Calif., Nov. 4 Nek...ts financial results for the third quarter ended S... ended September 30, 2009 improved to $31.0 millio... $37.0 million or $0.40 per share in the third qua...provements to its operating efficiencies as compar...
Breaking Biology Technology:WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9DIATHERIX Laboratories Presents at Homeland Security Conference 2Nektar Therapeutics Reports Third Quarter 2009 Financial Results 2Nektar Therapeutics Reports Third Quarter 2009 Financial Results 3Nektar Therapeutics Reports Third Quarter 2009 Financial Results 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 5Nektar Therapeutics Reports Third Quarter 2009 Financial Results 6Nektar Therapeutics Reports Third Quarter 2009 Financial Results 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 8Nektar Therapeutics Reports Third Quarter 2009 Financial Results 9Nektar Therapeutics Reports Third Quarter 2009 Financial Results 10
...it into state information technology projects near...stly IT project. , ,According to a report in the ... of Workforce Development has decided to stop wor...rack unemployment claims. The system, known as Enh..., or EnABLES, was supposed to replace a system use...
...vately-held biotechnology company, has completed w...y by raising an additional $500,000 to pursue a ne... , ,Alex Vodenlich, president and CEO of GenTel, ...be announced until next month during an open house... Fitchburg Technology Campus . , ,Some observers b...
...wth in the community and provide opportunities for...he city of Whitewater and the Wisconsin Innovat...g a business incubator, according to a report in t...t year received a $10,000 state grant to determine...l incubators throughout the nation, will not limit...
Other Biology Technology:State of Wisconsin dumps another tech project 2New angel capital centered on GenTel agreement with big pharma 2
(Date:11/4/2009)...t. 20 DigitalPersona, Inc., a lead...tions, today announced that WAND Corporation, a le... quick-service restaurants, has integrated Digital...sic POS solutions. WAND,s quick-service customers ...r accountability and deter unauthorized manager ov...
(Date:11/4/2009)...Newswire/ -- What,s the cost of saving a teenage l...resulting from prescription medication abuse, ther...wever, may be unaware that the lock-boxes they,ve ...ticking timebomb of prescription drugs. That,s why...medical supplies, has formed an exclusive partners...
(Date:11/4/2009)...ewswire-FirstCall/ -- BIO-key International, Inc. ...ed biometric identification software is showcasing...TXPO conference being held at the New Orleans Conv...l provide hands-on product demonstrations of its s... #424. Also, at 5 PM on Monday, October 26, Peter ...
Breaking Biology News(10 mins):WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3BIO-key(R) International Exhibiting at AABB TXPO 2Restless Legs May Vary by Race and Gender 60537 1Restless Legs May Vary by Race and Gender 60537 2Food Stamps Help Stave Off Hunger in Many U S Homes 60535 1Food Stamps Help Stave Off Hunger in Many U S Homes 60535 2Nicotine Patch Plus Lozenge Best for Quitting Smoking 60533 1Nicotine Patch Plus Lozenge Best for Quitting Smoking 60533 2Nicotine Patch Plus Lozenge Best for Quitting Smoking 60533 3
...n the human body or under the Earth,s crust, model...Physicians and geologists will be meeting at the U... have in common. , Through a partnership betwee...he Corporation, experts in biomedical and seismic ...ross-collaboration in imaging. The UH Imaging Sym...
... will provide an introduction to the basics of bu...ry schools at a free seminar, open to the public, ...m. in Kupfrian Hall, will include a review of the ... , Evans, a registered architect, i...ture and Building Science Research at the New Jers...
...horror movie, the swarm of bacteria ripples purpos... , Researchers at the University of Iowa are stud...hus) , a bacterium commonly found in soil, which p... in the bacterial world, M. xanthus is harmless ...o destroy harmful bacteria on surfaces or in human...
Other Biology News:Similarities in imaging the human body, Earth's crust focus of conference at UH 2Predatory bacterial swarm uses rippling motion to reach prey 2Predatory bacterial swarm uses rippling motion to reach prey 3
pLenti6/V5 Directional TOPO Cloning Kit from Invitrogen
...abbit polyclonal to Kv4.2 Immunogen Synthetic pe...orresponding to amino acids 23-43 of Rat Kv4.2. R...ected to cross-react with Human (100% identity wit..., Rabbit (100% identity with immunogen) and Ferret...
Human Angiogenesis Antibody Array 2.1 (8) Kit, RayBio from Raybiotech, Inc.
CryoPlus Square Rack, CP-13-2-CW/100, 27-11/32" OAH from Thermo Scientific
Biology Products: